Welcome: Guest | Site Use Options | Register | Login |

H Lundbeck A/S

Ottiliavej 9
Valby , 2500
 Synopsis: Business Condition
Year Founded N/A
Employment 5,379
Sector N/A
Industry N/A
H Lundbeck A/S
     Last modified on: 6/25/2013

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. The Company is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, including Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. The Company’s product portfolio includes such pharmaceuticals, as Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. Additionally, the Company had a number of products in development phases. As of December 31, 2012, it was active through subsidiaries in 57 countries, including Argentina, Australia, Denmark, China, Russia, the United States and the United Kingdom, among others.


SBIR firms in the news

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920